Engineering Tunable Helper Lipid Architecture to Improve Messenger RNA Lipid Nanoparticle Performance
Year: 2026
Type: article
Abstract: Helper lipids are essential structural components of lipid nanoparticles (LNPs), yet systematic design principles linking helper lipid architecture to messenger RNA (mRNA) delivery performance remain poorly defined. Here we identify helper lipid architecture as a major, largely unexplored design lever for optimizing LNP performance. Using a modular library of more than 80 rationally designed helper lipids, we show that systematic variation in headgroup chemistry, linker topology, and tail cardinality reshapes both LNP biophysical behavior and biological performance. Martini molecular dynamics (MD) simulations combined with multimodal structural analyses reveal that high-performing scaffolds undergo a pH-dependent transition into fusogenic inverse hexagonal-like ordering, substantially lowering the energetic barrier for endosomal escape. These performance gains persist across the clinically relevant ALC-0315 and DLin-MC3-DMA platforms, establishing helper lipid architecture as a transferable design parameter across distinct ionizable lipid chemistries. Translating these design principles into function, optimized helper lipid formulations restore hepatic protein expression in a mouse model of ornithine transcarbamylase (OTC) deficiency and increase antigen expression and immunogenicity in both preclinical models and in the in vitro human MIMIC platform. Together, these findings establish helper lipids as tunable molecular actuators of potency, tolerability, and stability, offering an engineering framework for next-generation mRNA vaccines and therapeutics.
Source: Advanced Materials
DOI: 10.1002/adma.75746
Authors: Shrirang Karve(Conceptualization, Investigation, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing), Neha Kaushal(Conceptualization, Investigation, Methodology, Visualization, Writing – review & editing), Hanming Zhang, Chetan Poojari(Formal analysis, Investigation, Methodology, Writing – original draft), Dipen Parande, Saket Dolare, Lingyun Liu, Zhongyu Li, Trent P. Northen, Jackie Tang, Jae‐Heon Kim, Mengwei Sun, Ana Kume, Krishna Chaitanya Suddala, Chung Li Wu, Allison Dauner, Danielle McCulley, Alex Shumate, David Forgacs, Ranjitha Uppala, Jose Salvatico, Rose Jolicoeur, Heesik Yoon, Ramesh Dasari, Saswata Karmakar, Zhen Hu, Ashish Sarode, Amita Vaidya, Younan Ma, Aurélie Deliot, Solene Bechelli, Michael Rieger(Project administration), Anusha Dias, Sudha Chivukula, Brian Schanen, Hongfeng Deng(Conceptualization, Project administration), Frank DeRosa(Project administration, Writing – review & editing), Regis Gervier(Project administration, Writing – review & editing)
Institutions: Sanofi (France), Sanofi (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $6,070
Funder: Sanofi
OpenAlex ID: W7235019629
